Tuesday, April 30, 2019

US FDA News: FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicines

FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicines - eszopiclone, zaleplon and zolpidem
Read more: FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicines